Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

Author： Wang Xu-Kai Zhang Ye Yang Cheng-Ming Wang Yan Liu Guang-Yao

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.6, 2006-01, pp. : 341-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antithrombotic therapy in ST-segment elevation myocardial infarction

By Wong Cheuk-Kit White Harvey D

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin in Acute Coronary Syndromes

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Enoxaparin: A Review of its Use in ST-Segment Elevation Myocardial Infarction

By Carter Natalie J. McCormack Paul L. Plosker Greg L.

Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. : 691-710

Adis International

Access to resources Recommend Favorite

Optimizing the Use of Thrombolytics in ST-Segment Elevation Myocardial Infarction

By Morse Michael A. Todd Josh W. Stouffer George A.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1945-1966

Adis International

Access to resources Recommend Favorite

Bivalirudin: In Patients with ST-Segment Elevation Myocardial Infarction

By Curran Monique P.

Drugs, Vol. 70, Iss. 7, 2010-05 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite